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Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) mainly infects porcine alveolar macrophages (PAMs), resulting
in porcine reproductive and respiratory syndrome (PRRS) in pigs. Most of the transcriptomic studies on PAMs infected with
PRRSV conducted thus far have made use of microarray technology. Here, we investigated the transcriptome of PAMs in
vitro at 12 h post-infection with two European PRRSV strains characterized by low (Lelystad, LV) and high (Lena) virulence
through RNA-Seq. The expression levels of genes, isoforms, alternative transcription start sites (TSS) and differential
promoter usage revealed a complex pattern of transcriptional and post-transcriptional gene regulation upon infection with
the two strains. Gene ontology analysis confirmed that infection of PAMs with both the Lena and LV strains affected
signaling pathways directly linked to the innate immune response, including interferon regulatory factors (IRF), RIG1-like
receptors, TLRs and PKR pathways. The results confirmed that interferon signaling is crucial for transcriptional regulation
during PAM infection. IFN-b1 and IFN-av, but not IFN-a, were up-regulated following infection with either the LV or Lena
strain. The down-regulation of canonical pathways, such as the interplay between the innate and adaptive immune
responses, cell death and TLR3/TLR7 signaling, was observed for both strains, but Lena triggered a stronger down-regulation
than LV. This analysis contributes to a better understanding of the interactions between PRRSV and PAMs and outlines the
differences in the responses of PAMs to strains with different levels of virulence, which may lead to the development of new
PRRSV control strategies.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a
viral disease that causes substantial economic losses to the swine
industry [1,2]. The PRRS virus (PRRSV) consists of a positive-
sense single-stranded RNA molecule that is14.5 kb in length and
has nine open reading frames. PRRSV strains can be divided into
two groups, the European and North American genotypes, based
on genetic and antigenic properties [3]. The European PRRSV
genotype is divided into three subtypes: the mild pan-European
subtype 1 (prototype virus: Lelystad virus, LV) and the more
virulent eastern European subtypes 2 and 3 (prototype virus: Lena)
[4]. The Lena virus has been found to be more virulent than the
Lelystad virus [5]. Infection studies showed that the expression
levels of IFN-a, IL-10, IL-12 and TNF-a were higher in Lena-
infected pigs than in LV-infected pigs [6–8]. Differences in
virulence between the PRRSV strains are related to their
immunomodulatory properties and replication capacity [9,10].
Nevertheless, Morgan et al. [11] found that the ‘‘SU1-bel, subtype
3’’strain from Belarus exhibited high virulence as a consequence of
an enhanced inflammatory response, rather than an increased
replication capacity.
PRRSV induces a strong humoral response; however, this
response is not effective at controlling the virus, and a persistent
infection frequently develops [12,13]. The genetic diversity of
PRRSV strains has been extensively characterized, and the
correlation between their genetic diversity and geographical/
temporal distances has been investigated to reveal the mechanisms
of viral spreading [14–16]. Many strategies for controlling PRRSV
transmission have been proposed but have generally shown little
success, which has stimulated the search for new ways to control
PRRSV transmission, including the possibility of using genetic
breeding to achieve resistance to PRRSV [17].
Pulmonary alveolar macrophages (PAMs) are the main target
cells for PRRSV infection, and many gene expression studies have
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explored the immune response of PAMs to PRRSV. Such studies
have shown that the expression levels of MX1, USP, IFN-b, IL-10
and TNF-a are affected by PRRSV infection [18,19]. Overall,
these analyses suggest that PRRSV subverts host defenses by
inhibiting the expression of pro-inflammatory cytokines [20–22]
and stimulating weak production of IFN-a [reviewed in 23].
RNA-Seq is increasingly being used to study gene expression, as
it provides unbiased profiles, compared to microarrays [24,25],
and can be extremely accurate if a sufficient level of coverage is
obtained [26]. Validation techniques, such as qPCR [27] and
spike-in RNA [28], have corroborated the accuracy of RNA-Seq.
One advantage of RNA-Seq over microarrays is that, in addition
to gene expression, RNA-Seq data can be used to identify
transcription start sites (TSS), splicing variants and differential
promoter usage [28]. Annotations of the human genome suggest
that a high proportion of protein-coding genes exhibit alternative
promoters, and aberrant promoter usage has been found to be
associated with various diseases [29].
In this study, RNA-Seq was used to characterize gene
expression, splice variants, TSSs and differential promoter usage
in PAMs infected with either LV (subtype 1, low virulence) or
Lena (subtype 3, high virulence). The PAM signaling pathways
that were affected by PRRSV infection were investigated and were
found to differ following infection with the two PRRSV strains.
The obtained data confirmed that many signaling pathways are
potentially involved in the host immune response to PRRSV
infection and that the regulation of interferon signaling is strongly
modulated during PAM infection. In contrast to infection with
LV, infection with Lena down-regulated the pathways involved in
the interplay between the innate and adaptive immune response,
cell death and TLR3/TLR7 signaling. Additionally, we also
highlight many differences in splicing isoforms, TSSs and
differential promoter usage between LV and Lena infections.
Materials and Methods
Animals, cells and library preparation
Pulmonary alveolar macrophages were collected from three 3-
week-old piglets, which were the offspring of hybrid sows (JSR
Genepacker 90 English: Landrace x Large White) and Pietrain
boars from a PRRS-negative herd. The PRRSV- and PCV2-
negative status of the piglets was confirmed via an immunoper-
oxidase monolayer assay (IPMA) and PCR, respectively. The
piglets were treated daily with 1 ml of enrofloxacin (5% solution)
and 1 ml of lincospectin/spectinomycin (5 or 10% solution) for 3
days to eliminate bacterial pathogens and then were sacrificed one
week later via intravenous injection with a lethal dose of Na-
pentobarbital (20 ml/animal) in the jugular vein. The sacrifice
procedure was carried out by a technician certified in Laboratory
Animal Science (Felasa Category C). The PAMs were collected by
broncho-alveolar lavage and frozen in liquid nitrogen as described
by Wensvoort et al. [30].
The animals were housed at the Faculty of Veterinary Medicine
of Ghent University (Belgium). All experimental procedures and
the sacrifice of the animals were conducted in compliance with the
relevant legislation on animal experiments (EU Directive 2010/63)
and with the approval of the local ethical committee.
Prior to infection, the PAMs were thawed and cultured for 48 h,
as described by Delputte et al. [31]. The primary culture from
each of the three animals was split into three fractions: one fraction
was infected at a multiplicity of infection (MOI) of 0.5 with the LV
strain; the second was inoculated at a MOI of 0.5 with the Lena
strain; and the third was maintained as a control (mock
inoculated). The cells were collected at 12 h post-infection for
transcriptome analysis. All of the infection experiments and
controls were performed in duplicate. One of each duplicate was
used to assess the percentage of infected cells. After 12 h, the cells
were fixed in acetone-100% methanol at 220uC, and the infected
cells were detected via immunoperoxidase staining with the
monoclonal anti-nucleocapsid protein antibody P3/27 (48),
followed by incubation with a horseradish peroxidase-labeled goat
anti-mouse secondary antibody and development with a substrate
solution containing 3-amino-9-ethylcarbazole. Viral antigen-pos-
itive cells and total cells were counted using an Olympus light
microscope (Olympus Optical Co., Hamburg, Germany), and the
percentage of infected cells was calculated. Three microscopic
fields and a minimum of 200 cells per field were counted for each
experimental condition.
Total RNA was extracted from the PAMs using TRIzol
(Invitrogen Life Technologies, Milan-Italy) and RNeasy columns
(Qiagen). RNA quality was assessed via microcapillary electro-
phoresis on an Agilent 2001 Bioanalyzer (Agilent Technologies)
with RNA 6000 Nanochips. RNA was quantified using spectro-
photometry (ND-1000; NanoDrop Technologies).
cDNA libraries were constructed using RNAfrom the LV-,
Lena- or mock-infected PAMs. A total of nine cDNA libraries
were obtained using TruSeq Sample Prep Kits (Illumina Inc., San
Diego, CA) and were sequenced via 26100 paired-end sequencing
on an IlluminaHiSeq 2000 instrument. The obtained sequences
were submitted to the Sequence Read Archive (SRA) at NCBI
(SRX352447).
The Laboratory of Virology has been acknowledged by the
Belgian Federal Agency for the Safety of the Food Chain (FASFC)
for its work with experimental animals, including pigs (national
approval number LA1400076). As euthanasia was the only action
performed on the animals, no approval was required by the local
ethical committee (Article 1, 5f, EU Directive 2010/63).
Quality check, mapping, assembly and visualization of
the sequenced reads
Sequence visualization and statistical analyses were performed
with FASTQC (http://www.bioinformatics. bbsrc.ac.uk/projects/
fastqc). Sickle software (https://github.com/najoshi/sickle) was
employed to retrieve the paired sequences with quality scores
above a threshold of 20 and a length greater than 50 bp. The
reads passing the quality criteria were processed and aligned to the
reference pig genome (Build Sus_scrofa.Sscrofa10.2.71.) using
TopHat v2.0.8 [32], and a maximum of 2 mismatches were
allowed when mapping the reads to the reference genome. The
default parameters for TopHat were used [32]. The mapping
results were then used to identify ‘‘islands’’ of expression, which
can be interpreted as potential exons. The mapping results were
visualized using the UCSC genome browser [33] and the
Integrative Genomics Viewer (IGV) software, which is available
at http://www.broadinstitute.org/igv/.
Transcript assembly and abundance estimation
Transcript assembly and abundance estimation were performed
using two methods: one for the genes and the other for the
remaining features (isoforms, TSS and promoters).
The aligned reads were further processed using Cufflinks v2.1.1
[34] (Figure S4-A) to infer the splicing structure of each gene using
the optimal reconstruction of the gene model, which was
determined using a rigorous statistical model. The reads were
assembled into transcripts by forcing Cufflinks to use not just the
existing gene annotations during the assembly of transcripts but
instead to construct the transcripts based on both the reference
gene annotations and the sequence data. This approach allows
Porcine Alveolar Macrophages Infection with PRRSV
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Cufflinks to identify new potential alternative transcription and
splicing events. Confidence intervals for the FPKM estimates were
calculated using a Bayesian inference method [35]. Once all of the
short read sequences were assembled with Cufflinks, the output
files were merged via the Cuffmerge function and processed using
Cuffcompare, along with a reference GTF annotation file
downloaded from the Ensembl database.
The HTseq python package (http://www-huber.embl.de/
users/anders/HTSeq/doc/count.html) was employed to generate
an unambiguous table of counts per gene to estimate expression
levels. The HTseq-count function was employed, with ‘union’ in
overlapping mode and ‘gene’ as a feature.
Differential expression analysis
The cells obtained from each pig were divided into three
batches to represent the two treatment conditions (LV-infected
orLena-infected) and the control (mock-infected). To remove
baseline differences between the pigs, a paired design was
employed, in which treatment values were subtracted from control
values for each pig prior to the computation of the average and
variance. Differential expression analysis was performed using the
EdgeR package [36], which employs the table of counts per gene
generated by HTSeq as an input.
Using edgeR, a general linear model was generated to test for a
treatment (infection with Lena or LV) effect. This method is based
on the negative binomial distribution and uses the conditional
weighted likelihood to moderate the level of overdispersion across
the sequences. Three pairwise comparisons of gene expression
levels were performed for the three combinations of treatments: i)
LV vs. mock, ii) Lena vs. mock and iii) LV vs. Lena.
The Cuffdiff function was used to assess the presence and
frequency of different isoforms, TSSs and differential promoter
usage. Briefly, Cuffdiff starts by modeling the variability in the
fragment count for each gene across the replicates corresponding
to the mock, LV and Lena samples. Second, the counts for each
isoform are estimated in each replicate, taking into consideration
the uncertainty arising from ambiguously mapped reads. Finally,
Cuffdiff estimates the count variances for each transcript in each
sample, and this information is used in statistical testing to report
the differentially expressed transcripts, including the isoforms,
TSSs and differential promoter usage [34]. Cuffdiff was used to
perform three pairwise comparisons of the observed isoforms,
TSSs and promoter usage: i) LV vs. mock ii) Lena vs. mock and iii)
LV vs. Lena. For all of the analyses, a feature was considered
significant if the false discovery rate (FDR) was less than 0.05 and
the fold change (FC) difference was greater than or equal to 1.5.
Functional analysis of gene lists through Ingenuity
Pathways Analysis (IPA)
IPA (http://www.ingenuity.com) was used to identify the most
significant molecular networks, biological functions and canonical
metabolic pathways. The p-values associated with the biological
processes or pathway annotation were calculated according to the
right-tailed Fisher’s Exact Test. Affected genes were first matched
to their corresponding gene names in IPA. The obtained lists were
then subjected to IPA to reveal the canonical pathways and
biological functions that were significantly associated with the gene
lists, using the default ‘‘universe’’ of genes and endogenous
chemicals in the IPA library.
Results
1. Expressed and differentially expressed genes, isoforms
and TSSs, as well as differential promoter usage,thein LV
vs. mock, Lena vs. mock and LV vs. Lena analyses
The percentages of PAMs infected by LV and Lena were 21%
and 16% on average, respectively. This result was confirmed using
quantitative PCR; the threshold cycle (Ct) values obtained were
15.6 and 20.5 for LV and Lena, respectively.
Nine libraries obtained from PAMs corresponding to LV (3
samples), Lena (3 samples) and mock infections (3 samples) were
sequenced. The mean numbers of reads produced per strand were
14,483,298, 17,381,381 and 10,473,546 for the LV, Lena and
Mock groups, respectively (Table S1-A). Data filtering using
FASTQC and Sickle excluded between 11% and 17% of the reads
(Table S1-B). Between 73% and 87% of the total paired reads
passing the quality test were mapped to the reference pig genome
(Build Sus_scrofa.Sscrofa10.2.71).
In total, 29,900 annotated genes and 58,347 isoforms were
expressed in both the infected and non-infected PAMs. Of these
genes, 0.46% were expressed at more than 10,000 FPKM, 0.6%
between 1000 and 10,000 FPKM, 3.14% between 100 and 1000
FPKM and 40.64% between 1 and 100 FPKM. The genes with
the highest expression were XLOC_009444 (14,122,900 FPKM in
the LV-infected cells), XLOC_027735 (13,467,000FPKM in the
Lena-infected cells) and SCARNA16 (13,133,300 FPKM in the
LV-infected cells). The differentially expressed features and the
intersection of the differentially expressed genes, isoforms, TSSs
and differential promoter usage observed in the LV vs. mock, Lena
vs. mock and LV vs. Lena comparisons are shown in Figure 1 (1.I,
1.II, 1.III and 1.IV).
1.1. Canonical pathways and biological functions
differentially expressed in the LV- vs. mock-infected
samples. A total of 446 differentially expressed genes were
identified between the mock-infected and LV-infected PAMs
(Table S2). Among these genes, 107 presented at least two isoforms
that were differentially expressed between the mock- and LV-
infected PAMs, and one was differentially regulated at the
promoter level (Figure 2.I). In total, 413 genes could be mapped
to the IPA database to assign gene ontology. The top five
canonical pathways identified as being differentially expressed in
the LV vs. mock via IPA were ‘‘Interferon Signaling’’, ‘‘Activation
of IRF by Cytosolic Pattern Recognition Receptors’’, the ‘‘Role of
Pattern Recognition Receptors in Recognition of Bacteria and
Viruses’’, the ‘‘Role of PKR in Interferon Induction and Antiviral
Response’’ and ‘‘Retinoic Acid Mediated Apoptosis Signaling’’
(Table 1A). All of these pathways are interconnected and are
directly involved in the immune response to viral infection. In the
infected cells, the ‘‘Interferon Signaling’’ pathway, which is central
to the innate defense mechanisms of the host against viral
infection, included 12 up-regulated genes: IFIT1, IFIT3, IFITM1,
IFNb1, IRF1, JAK2, MX1, OAS1, PSMB8, SOCS1, STAT1 and
STAT2. An additional 14 up-regulated genes were involved in the
activation of IRF by the cytosolic pattern recognition receptor
pathway (ADAR, DDX58, DHX58, IFIH1, IFIT2, IFNb1, IL10,
IRF7, ISG15, NFKBIA, STAT1, STAT2, TNF and ZBP1). The
‘‘Role of Pattern Recognition Receptors in Recognition of
Bacteria and Viruses’’ pathway, which generally leads to the
serine phosphorylation of IRF3 and IRF7 [37], involved IRF7, but
not IRF3. The ‘‘Role of PKR in Interferon Induction and
Antiviral Response’’ and ‘‘Retinoic Acid Mediated Apoptosis
Signaling’’ pathways were up-regulated and shared four genes
(CASP8, BID, IFNb1 and IRF1).
Porcine Alveolar Macrophages Infection with PRRSV
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e91918
The IFN-b gene was common to all of the top canonical
pathways, which is consistent with the previously reported
fundamental role of this gene in the response of pigs to PRRSV
(reviewed in [23]). Interestingly, IFN-b and IFN-av were both up-
regulated following LV and Lena infection, but the expression of
IFN-b was higher in the PAMs infected with LV (Figure 3).
Among the top ten biological functions that differed between
the LV-and mock-infected samples (Table 2A), the categories
‘‘Cell death of immune cells’’, ‘‘Leukocyte infection’’, other
functions related to the hematological system (the numbers of
leukocytes, mononuclear leukocytes, lymphocytes and T lympho-
cytes) and the ‘‘Cell death/survival’’ pathway were all up-
regulated. Only two biological functions (apoptosis of phagocytes
and cellular homeostasis) were down-regulated.
1.2. Canonical pathways and biological functions
differentially expressed in the Lena- vs. mock-infected
samples. Three of the top five canonical pathways modulated
by the infection of PAMs with Lena were shared with those
affected by LV infection: ‘‘Activation of IRF by Cytosolic Pattern
Recognition Receptors’’, ‘‘Interferon Signaling’’ and the ‘‘Role of
Pattern Recognition Receptors in Recognition of Bacteria and
Viruses’’ (Table 1B). The two canonical pathways specific to Lena
infection were the ‘‘Role of RIG1-like Receptors in Antiviral
Innate Immunity’’, which is involved in the recognition of viral
RNA [38–40], and the ‘‘Role of Hypercytokinemia/hyperchemo-
kinemia in the Pathogenesis of Influenza’’.
Among the top ten biological functions, the ‘‘cell death of
immune cells and lymphocytes and apoptosis of lymphocytes and
Figure 1. Venn diagram illustrating the significantly affected genes (I), isoforms (II), TSSs (III) and differential promoter use (VI)
found in the LV vs.mock (A), Lena vs.mock (B) and LV vs. Lena (C) comparisons. I. Venn diagram illustrating the significantly affected genes
found in the LV vs. mock (A, 446), Lena vs. mock (B, 153) and LV vs. Lena (C, 241) comparisons. II. Venn diagram illustrating the significantly affected
isoforms found in the LV vs. mock (A, 187), Lena vs. mock (B, 72) and LV vs. Lena (C, 34) comparisons. III. Venn diagram illustrating the significantly
affected TSSs found in the LV vs. mock (A, 240), Lena vs. mock (B, 93) and LV vs. Lena (C, 50) comparisons. VI. Venn diagram illustrating the
significantly affected promoters found in the LV vs. mock (A, 14), Lena vs. mock (B, 6) and LV vs. Lena (C, 7) comparisons. The blue circle, ‘‘A’’,
corresponds to the LV vs. mock case (I. significantly affected genes, II. significantly affected isoforms, III. significantly affected TSSs and VI. significantly
affected promoters). The green circle, ‘‘B’’, corresponds to the Lena vs. mock case (I. significantly affected genes, II. significantly affected isoforms, III.
significantly affected TSSs and VI. significantly affected promoters). The purple circle, ‘‘C’’, corresponds to the LV vs. Lena case (I. significantly affected
genes, II. significantly affected isoforms, III. significantly affected TSSs and VI. significantly affected promoters).
doi:10.1371/journal.pone.0091918.g001
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T lymphocytes’’ was up-regulated (Table 2B). Other up-regulated
functions related to virus infection included the invasion of
phagocytes, chemotaxis of antigen-presenting cells and the
inflammatory response. Cell death/survival pathways were less
affected by Lena infection than by LV infection and involved
different sets of genes (Figure S1-A and B).
1.3. Canonical pathways and biological functions
differentially expressed in the LV-and Lena-infected
samples. A direct comparison between the LV and Lena
infections was performed at the gene, isoform and promoter levels
(Table S2). The top five canonical pathways (not taking into
account the canonical pathways already found to be differentially
expressed in the LV vs. mock and Lena vs. mock) were ‘‘IL-15
production’’, ‘‘TREM1 signaling’’, ‘‘Communication between
innate and adaptive Immune Cells’’, ‘‘Crosstalk between dendritic
cells and natural killer cells’’ and the ‘‘Role of JAK2 in hormone-
like cytokine signaling’’ (Table 1C). Lena infection triggered the
up-regulation of RPL31 (FC = 243.87), IL-8 (FC = 144), PA2G4
(FC = 75) and CXCL2 (FC = 9.18), while other genes were up-
regulated following LV infection, including P2RY2 (FC = 29.24),
CCL2 (FC = 13.18), WNT4 (FC = 11.31), ACADVL (FC = 7.26),
CXCL10(FC = 3.97) and IFNb1 (FC = 3.48).
Interestingly, RPL31 and IL8 were almost exclusively expressed
after Lena infection (Figure S2-A and B), while other genes,
including CCL2 and ACADVL, were differentially regulated by
infection with both strains, although to different extents (Figure
S2-C and D). CXCL10 exhibited three isoforms, but only one
isoform (TCONS_00046382) was differentially expressed (Figure
S3-A) between the two strains. This gene was also regulated at the
TSS level; we identified 3 TSSs, of which one (TSS31082) was
differentially regulated between the LV and Lena infections
(Figure S3-B).
Figure 2. Venn diagram illustrating the significantly affected genes (A, chartreuse color), isoforms (B, violet color) and differential
promoter use (C, orange color) found in the LV vs. mock (I), Lena vs. mock (II) and LV vs. Lena (III) comparisons. I. Venn diagram
illustrating the significantly affected genes (A, 446), isoforms (B, 187) and differential promoter use (C, 14) found in the LV vs. mock comparison. II.
Venn diagram illustrating the significantly affected genes (A, 153), isoforms (B, 72) and promoters (C, 6) found in Lena vs. mock comparison. III. Venn
diagram illustrating the significantly affected genes (A, 241), isoforms (B, 34) and promoters (C, 7) found in LV vs. Lena comparison. The chartreuse
circle, ‘‘A’’, corresponds to the differentially expressed genes (I. LV vs. mock, II. Lena vs. mock and III. LV vs. Lena). The violet circle, ‘‘B’’, represents the
differentially expressed isoforms (I. LV vs. mock, II. Lena vs. mock and III. LV vs. Lena). The orange circle, ‘‘C’’, corresponds to the differentially used
promoters(I. LV vs. mock, II. Lena vs. mock and III. LV vs. Lena).
doi:10.1371/journal.pone.0091918.g002
Porcine Alveolar Macrophages Infection with PRRSV
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e91918
2. Transcriptional and post-transcriptional regulation and
differential promoter usage in PAMs after infection with
the LV and Lena PRRSV strains
Differentially expressed isoforms with different TSSs are
transcriptionally regulated, while differentially expressed isoforms
with the same TSSs are regulated at the post-transcriptional level
[28]. For the genes involved in the top canonical pathways
identified in the previous analyses (LV vs. mock, Lena vs. mock and
LV vs. Lena), the regulation of PRRSV infection was investigated
at the levels of the transcripts, isoforms and TSSs (Figure S4-B).
Three groups of genes were defined:
(i) Genes with one isoform and one TSS; these genes were
classified as ‘‘un-spliced and transcriptionally regulated’’
genes and included TNF, BID, CASP8, ZC3HAV1, IL8,
CCR5, CCL4, CCL2 and TLR4 (Figure S5-Group 1).
(ii) Genes with more than one isoform and one TSS;these genes
were classified as ‘‘Spliced and post-transcriptionally regu-
lated’’ genes and included IFNb1, STAT1, TIPARP, MICB,
IRF7, CASP1, IL1B, OAS2 and STAT2 (Figure S5-Group 2).
(iii) Genes with more than one isoform and more than one TSS.
In this group, some isoforms of a given gene are
transcriptionally regulated, while others are post-transcrip-
tionally regulated. This group was classified as ‘‘Spliced and
both transcriptionally and post-transcriptionally regulated’’.
This group could be further differentiated into two sub-
groups (Figure S5-Group 3): (a) ‘‘Spliced genes whose
isoforms are all transcriptionally regulated’’, which included
IFIT3, IFIT1, IRF1, ZBP1, ISG15, OAS1, IFITM1, TLR7,
TNFSF10, TNFRSF10A and CXCL10; and (b) ‘‘Spliced genes
whose isoforms are either transcriptionally or post-transcrip-
tionally regulated’’, which included IL10, NFKBIA, EI-
F2AK2, PARP14, PSMB8, DHX58, ADAR and RNASEL.
The analysis of differential promoter usage offers an additional
perspective to the overview of gene regulation triggered by
PRRSV infection. Therefore, we considered the different isoforms
that showed the same TSS yields and presented transcripts
produced from different start sites [Figure S4-B]. This analysis
suggested that 14, 6 and 7 genes were differentially regulated at the
promoter level in the LV vs. mock, Lena vs. mock and LV vs. Lena
comparisons, respectively (Table S2). Two genes (PSMB8 and
TIPARP7) expressed two isoforms, of which one was exclusively
expressed in one PRRSV strains (Lena or LV) but not in the other
(Figure S5-Group 3 and 2). Moreover, many genes exhibited
Table 1. Lists of the 5 top canonical pathways and the corresponding affected genes in the LV vs. mock (A), Lena vs. mock (B) and
LV vs. Lena (C) comparisons.
A. LV vs. mock infection
Ingenuity Canonical Pathways 2log(p-value)* Ratio£ Molecules&
Interferon Signaling 1.08E+01 3.87E-01 IFIT3,SOCS1,IFIT1,OAS1,MX1,IFNB1, IFITM1,STAT2,PSMB8,JAK2,STAT1,IRF1
Activation of IRF by Cytosolic Pattern Recognition
Receptors
9.97E+00 2.64E-01 DHX58,IL10,ZBP1,IFNB1,ADAR,ISG15, IFIH1,IRF7,NFKBIA,DDX58,STAT2,IFIT2,
STAT1,TNF
Role of Pattern Recognition Receptors in
Recognition of Bacteria and Viruses
8.55E+00 1.78E-01 OAS1,OAS2,IL10,PIK3R1,IFNB1,RNASEL,
IFIH1,IRF7,DDX58,TLR7,CASP1,IL1B,PIK3CD, EIF2AK2,TLR3,TNF
Role of PKR in Interferon Induction and
Antiviral Response
7.03E+00 2.5E-01 NFKBIA,IFNB1,BID,EIF2AK2,TLR3,STAT1, CASP8,RNASEL,TNF,IRF1
Retinoic Acid Mediated Apoptosis Signaling 6.96E+00 2.16E-01 BID,CASP8,IFNB1,IRF1,PARP9,PARP11, PARP14,TIPARP,TNFRSF10A,TNFSF10,
ZC3HAV1
B. Lena vs. mock infection
Activation of IRF by Cytosolic Pattern Recognition
Receptors
1.04E+01 1.89E-01 DHX58,IFIH1,IRF7,DDX58,ZBP1,IFNB1,ADAR, IFIT2,TNF,ISG15
Role of Pattern Recognition Receptors in
Recognition of Bacteria and Viruses
8.09E+00 1.11E-01 IFIH1,OAS1,IRF7,OAS2,DDX58,IFNB1,PIK3CD, EIF2AK2,RNASEL,TNF
Role of Hypercytokinemia/hyperchemokinemia
in the Pathogenesis of Influenza
8.02E+00 2.26E-01 CXCL10,IL8,CCR5,CCL4,CCL2,IFNB1,TNF
Interferon Signaling 8.02E+00 2.26E-01 IFIT3,SOCS1,IFIT1,OAS1,MX1,IFNB1, IFITM1
Role of RIG1-like Receptors in Antiviral
Innate Immunity
4.89E+00 1.47E-01 DDX58,DHX58,IFIH1,IFNB1,IRF7
C. LV vs. Lena infection
IL-15 Production 4.65E+00 2.17E-01 IL15,IFNB1,JAK2,STAT1,IRF1
TREM1 Signaling 4.54E+00 1.21E-01 IL8,TLR4,CCL2,TLR7,JAK2,TLR3,TNF
Communication between Innate and
Adaptive Immune Cells
4.43E+00 9.76E-02 CXCL10,IL8,TLR4,IL15,TLR7,IFNB1,TLR3, TNF
Crosstalk between Dendritic Cells and
Natural Killer Cells
4.35E+00 9.52E-02 TLR4,MICB,IL15,TLR7,IFNB1,TNFSF10,TLR3,TNF
Role of JAK2 in Hormone-like Cytokine Signaling 3.92E+00 1.56E-01 SOCS1,SOCS2,JAK2,STAT1,SIRPA
*probability that a canonical pathway is significantly involved in the analysis.
£number of genes in the list involved in a certain canonical pathway divided by the number of genes in the IPA database involved in the same canonical pathway.
&genes involved in the corresponding canonical pathway.
doi:10.1371/journal.pone.0091918.t001
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different levels of expression of the various isoforms under
infection with one PRRSV strain vs. the other (PARP14, SOCS1,
IFIT1, MX1, IFOTM1, RNASEL, PIKSCD and TLR3; Figure S5).
Discussion
This study provides insights into the transcriptome of PAMs
infected with the LV and Lena PRRSV strains.
Canonical pathways and biological functions
differentially expressed in the LV vs. mock, Lena vs. mock
and LV vs. Lena analyses
The biological annotation of the immune response-related genes
that were differentially expressed in the PAMs during LV and
Lena infection can be interpreted using two sequential steps.
i) The role of the TLRs in mounting an immune response during
PRRSV infection has been confirmed [41,42]. Once activated,
IRF1, IRF2 and IRF7 translocate into the nucleus and induce the
transcription of IFN-b and IFN-av, but not IFN-a. IRF1, IRF2 and
IRF7 were all affected by LV infection, but only IRF7 was found to
be modulated after Lena infection. The fact that the PRRSV
strains provoked the expression of IFN-b, but not IFN-a, is in
agreement with previous experiments performed in PAMs and
dendritic cells in vitro [43–45].
(ii) Once secreted, IFN-b and most likely IFN-av are exported
to the extracellular space, where they bind to the IFN receptors,
provoking the recruitment of STAT1/STAT2 and inducing the
subsequent IFN-stimulated genes: IFIT1, IFIT3, IFITM1, ISG12,
ISG15, ISG20, PKR, IRF1, JAK2, MX1, OAS1, PSMB8, RNaseL and
SOCS1;all of these genes play a fundamental role in the host
immune response. Specifically, PKR dimerizes and phosphorylates
EIF2a to inhibit the translational process [45,46]. OAS1 is an IFN
inducer that is capable of inhibiting protein synthesis and viral
growth by degrading viral and cellular RNA [47]. ISG12, ISG15
and ISG20 are ubiquitin homologs involved in the regulation of
innate immunity [48]. MX1 exhibits antiviral activity [49].
The biological functions altered by Lena and LV infections were
focused on cell death/survival, which is considered an innate
defense mechanism. We observed considerable interplay between
cell death and cell survival, which might explain the discrepancies
reported in previous PRRS studies concerning apoptosis [50–52].
Figure 3. Gene expression of IFN-b and IFN-av genes in FPKM (Y axis). Top left: IFN-b expression in the mock, LV and Lena groups. IFN-b was
differentially expressed between both the LV and Lena groups when compared to the mock infection group. IFN-b was also expressed at a
significantly higher level in the LV group than in the Lena group. Lower right: IFN-av expression in the mock, LV and Lena groups. IFN-av was
differentially expressed between the LV and Lena groups from one side and the mock group from the other side. IFN-b was also expressed at a
significantly higher level in the LV group than in the Lena group.
doi:10.1371/journal.pone.0091918.g003
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Table 2. Lists of affected biological functions and the corresponding affected genes in the LV vs. mock (A) and Lena vs. mock (B)
comparisons.







A. LV vs. mock
cell death of
immune cells
1.89E-13 Increased 2.147 BID,CASP1, CASP8, CCL4, CCR5, CD274, CD38, CD5, DHX58, EIF2AK2, HAVCR2,
HCAR2, HSH2D, IDO1, IFNB1, IL10, IL15, IL15RA, IL1B, IL27, IL7R, IRF1, IRF2, IRF4,
JAK2, LGALS9, MCL1, MX1, NAMPT, NFKBIA, PARP14, PIK3CD, PIK3R1, PIM1, PMAIP1,




2.62E-13 Increased 2.297 ABCA1, ARNTL, B3GNT5, BID, CASP8, CCL2, CCL3L1/CCL3L3, CCR2, CCR5, CD274,
CD38, CD5, CXCL10, CYP27B1, DAPP1, DDX58, ELF1, ENTPD7, HAVCR2, HBEGF, HLA-
B, IDO1, IFNB1, IL10, IL15, IL15RA, IL1B, IL27, IL7R, IRF1, IRF2, IRF4, ISG15, JAK2,
LGALS9, MAEA, MAP3K8, MCL1, MXD1, NBN, NFKBIA, PDE4B, PIK3CD, PIK3R1, PIM1,
PIM3, PLAC8, PML, PPM1D, PRDM1, PTPN13, PYCARD, RFX5, RHOH, RICTOR,
SEMA4D, SOCS1, SOX4, STAT1, TCF4, TEC, TIMD4, TLR3, TNF, TNFAIP3, TNFRSF10A,
TNFSF10, TNFSF13B, VCAM1
Cell death 2.62E-13 Increased 2.297 ABCA1, ARNTL, B3GNT5, BID, CASP8, CCL2, CCL3L1/CCL3L3, CCR2, CCR5, CD274,
CD38, CD5, CXCL10, CYP27B1, DAPP1, DDX58, ELF1, ENTPD7, HAVCR2, HBEGF, HLA-
B, IDO1, IFNB1, IL10, IL15, IL15RA, IL1B, IL27, IL7R, IRF1, IRF2, IRF4, ISG15, JAK2,
LGALS9, MAEA, MAP3K8, MCL1, MXD1, NBN, NFKBIA, PDE4B, PIK3CD, PIK3R1, PIM1,
PIM3, PLAC8, PML, PPM1D, PRDM1, PTPN13, PYCARD, RFX5, RHOH, RICTOR,




1.61E-12 Increased 2.703 BID, CASP1, CASP8, CCL2, CCL4, CCR5, CD274, CD38, CD5, DHX58, EIF2AK2, HAVCR2,
HCAR2, HLA-B, HSH2D, IDO1, IFNB1, IL10, IL15, IL15RA, IL1B, IL27, IL7R, IRF1, IRF2,
IRF4, JAK2, LGALS9, MCL1, MX1, NAMPT, NFKBIA, PARP14, PIK3CD, PIK3R1, PIM1,





5.16E-12 Increased 3.212 ARNTL, B3GNT5, BID, CASP8, CCL2, CCR2, CCR5, CD274, CD38, CD5, CXCL10,
CYP27B1, DAPP1, DDX58, ELF1, ENTPD7, HLA-B, IFNB1, IL10, IL15, IL15RA, IL27, IL7R,
IRF1, IRF2, IRF4, ISG15, JAK2, LGALS9, MAP3K8, MCL1, NBN, NFKBIA, PIK3CD, PIK3R1,
PIM1, PIM3, PPM1D, PRDM1, PTPN13, PYCARD, RFX5, RHOH, SEMA4D, SOCS1, SOX4,
STAT1, TCF4, TEC, TIMD4, TLR3, TNF, TNFAIP3, TNFRSF10A, TNFSF13B, VCAM1
infection of
leukocytes
5.16E-12 Increased 3.212 ARNTL, B3GNT5, BID, CASP8, CCL2, CCR2, CCR5, CD274, CD38, CD5, CXCL10,
CYP27B1, DAPP1, DDX58, ELF1, ENTPD7, HLA-B, IFNB1, IL10, IL15, IL15RA, IL27, IL7R,
IRF1, IRF2, IRF4, ISG15, JAK2, LGALS9, MAP3K8, MCL1, NBN, NFKBIA, PIK3CD, PIK3R1,
PIM1, PIM3, PPM1D, PRDM1, PTPN13, PYCARD, RFX5, RHOH, SEMA4D, SOCS1, SOX4,
STAT1, TCF4, TEC, TIMD4, TLR3, TNF, TNFAIP3, TNFRSF10A, TNFSF13B, VCAM1
proliferation of
B lymphocytes
7.80E-12 Increased 3.218 ARNTL, B3GNT5, BID, CASP8, CCL2, CCR2, CCR5, CD274, CD38, CD5, CXCL10,
CYP27B1, DAPP1, DDX58, ELF1, ENTPD7, HLA-B, IFNB1, IL10, IL15, IL15RA, IL27, IL7R,
IRF1, IRF2, IRF4, ISG15, JAK2, LGALS9, MAP3K8, MCL1, NBN, NFKBIA, PIK3CD, PIK3R1,
PIM1, PIM3, PML, PPM1D, PRDM1, PTPN13, PYCARD, RFX5, RHOH, SEMA4D, SOCS1,
SOX4, STAT1, TCF4, TEC, TIMD4, TLR3, TNF, TNFAIP3, TNFRSF10A, TNFSF13B, VCAM1
quantity of T lymphocytes7.80E-12 Increased 3.218 ARNTL, B3GNT5, BID, CASP8, CCL2, CCR2, CCR5, CD274, CD38, CD5, CXCL10,
CYP27B1, DAPP1, DDX58, ELF1, ENTPD7, HLA-B, IFNB1, IL10, IL15, IL15RA, IL27, IL7R,
IRF1, IRF2, IRF4, ISG15, JAK2, LGALS9, MAP3K8, MCL1, NBN, NFKBIA, PIK3CD, PIK3R1,
PIM1, PIM3, PML, PPM1D, PRDM1, PTPN13, PYCARD, RFX5, RHOH, SEMA4D, SOCS1,
SOX4, STAT1, TCF4, TEC, TIMD4, TLR3, TNF, TNFAIP3, TNFRSF10A, TNFSF13B, VCAM1
apoptosis of
phagocytes




1.47E-10 Decreased 22.201 CASP1, CCL4, CCR5, EIF2AK2, HAVCR2, IL15, IRF1, LGALS9, MGLL, PIK3R1, SAMHD1,
STAT1, TNF
B. Lena vs. mock
cell death
of immune cells
4.78E-08 Increased 2.276 CCL4, CCR5, CD274, DHX58, EIF2AK2, HAVCR2, HCAR2, IFNB1, IL15RA, IL27, IL7R, IL8,
MX1, PARP14, PIK3CD, PPBP, RNASEL, SOCS1, TNF, TNFSF10
Cell death 8.23E-08 Increased 2.575 CCL2, CCL4, CCR5, CD274, DHX58, EIF2AK2, HAVCR2, HCAR2, IFNB1, IL15RA, IL27,
IL7R, IL8, MX1, PARP14, PIK3CD, PPBP, RNASEL, SOCS1, TNF, TNFSF10
Cell death of
lymphocytes








6.11E-07 Increased 2.921 CCL2, CCL4, CCL8, CCR5, CCRL2, CXCL10, EDN1, IFNB1, IL8, PDE4B, PIK3CD, PPBP,
TNF
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Comparison between Lena and LV infections
In this study, the replication rate was slightly higher in LV than
Lena strain. Similar results were obtained by Morgan et al. [11]
who reported no obvious differences in PRRSV replication
between the LV and the ‘‘SU1-bel, subtype 3’’ strain in vitro. This
differs from results of in vivo studies, in which a higher replication
rate was reported for Lena compared to other PRRSV subtype 1
strains [6]. Frydas et al [53] have shown that, while LV can
replicate in a restricted subpopulation of monocytic cells, Lena
appears to target an ample range of cell subpopulations to
disseminate within the mucosa. This finding might explain the
high replication rate of the Lena strain in vivo, as airway mucosal
surface is a common entry site for the virus [53].
i. Canonical pathways
Two canonical pathways might explain the differences in cell
death/survival that were reported for the LV and Lena PRRSV
strains: ‘‘IL-15 production’’ and ‘‘Role of JAK2 in Hormone-like
Cytokine Signaling’’.‘‘IL-15 production’’ involved five genes
(IFNb1, IL15, IRF1, JAK2 and STAT1), all of which were up-
regulated following LV infection compared to Lena infection. This
pathway is one hallmark of the survival and differentiation of NK
and T cells [54]. Furthermore, the ‘‘Role of JAK2 in Hormone-
like Cytokine Signaling’’ is involved in cell survival and
differentiation [55].
The ‘‘TREM1 signaling’’ pathway involved seven genes (CCL2,
IL8, JAK2, TLR3, TLR4, TLR7 and TNF), among which IL-8 and
TLR4 were up-regulated during Lena infection. It has been
reported that TREM1 activation is associated with increases in
TLR4 [56] and interleukin-8 (IL-8) expression [57]. Interestingly,
IL-8 was exclusively expressed during Lena and not LV infection,
while TLR4 expression in the LV group was close to null. This
finding suggests that TREM1 signaling is mostly specific to Lena
infection. Based on a meta-analysis, Badaoui et al. [58] reported
the possible involvement of TREM1 signaling during PRRSV
infection. This finding could partially explain the high inflamma-
tory response reported following Lena infection (Table S2), as
TREM1 is directly implicated in the enhancement of inflamma-
tion [59]. From a comparative analysis of PRRSV type 1 and
PRRSV type 2, Lee & Lee [60] reported that the up-regulation of
IL-8 only occurred 12 h after infection with PRRSV type 2 and
was not observed following infection with PRRSV type 1. As IL-8
is known to activate lymphocytes, basophils and neutrophils, its
modulation might play an important role in controlling the host
immune response.
The interplay between the innate and adaptive immune
response is a fundamental aspect of host-pathogen interactions
[61]. In this context, two related canonical pathways were found to
be differentially expressed in LV- and Lena-infected samples:
‘‘Communication between Innate and Adaptive Immune Cells’’
and ‘‘Crosstalk between Dendritic Cells and Natural Killer Cells’’.
Most of the genes involved in these two canonical pathways were
up-regulated to a greater extent by LV infection than by Lena
infection. This result suggests that a partial down-regulation of the
crosstalk between the innate and adaptive immune responses is
triggered by Lena infection. The connection between NK cells and
the DC pathway is required for optimal immune cell expansion
and activation [62], which might explain the relative decrease in
the immune response observed in the Lena-infected samples
compared to the LV-infected cells.
ii. Biological functions
The cell death/survival biological functions were strongly
activated during LV infection compared to Lena infection (Figure
S1). Moreover, screening the network interactions among the
genes involved in cell death/survival for both the LV and Lena
strains (Figure S1) showed that the canonical apoptosis pathway
signals (BID, CASP8, MCL1 and NFKB) were activated upon LV
infection, but not following Lena infection.
Weesendorp et al. [6] observed a higher apoptosis rate following
Lena infection than following LV infection in vivo. In other studies,
PRRSV was found to induce the apoptosis of lymphocytes and
macrophages; this would lead to a decreased host immune
response and allow the virus to persist in the host [63,64]. In
addition to the difficulty in directly comparing in vitro and in vivo
approaches, these discrepancies could be explained by ability of
Lena to exploit novel cell receptors to target a wider population of
Table 2. Cont.













2.43E-06 Increased 2.987 ADAR, CCL2, CD274, DDX58, DUSP5, EIF2AK2, IFNB1, IL15RA, IL27, IL7R, IL8, IRF7,
JAG1, PIK3CD, PML, RSAD2, SEMA4A, SOCS1, TNF
hematopoiesis of
myeloid progenitor cells
2.43E-06 Increased 2.987 ADAR, CCL2, CD274, DDX58, DUSP5, EIF2AK2, IFNB1, IL15RA, IL27, IL7R, IL8, IRF7,
JAG1, PIK3CD, PML, RSAD2, SEMA4A, SOCS1, TNF
cell movement
of PBMCs
2.43E-06 Increased 2.987 ADAR, CCL2, CD274, DDX58, DUSP5, EIF2AK2, IFNB1, IL15RA, IL27, IL7R, IL8, IRF7,
JAG1, PIK3CD, PML, RSAD2, SEMA4A, SOCS1, TNF
inflammatory response 2.53E-06 Increased 2.635 CCL2, CCL4, CCL8, CCR5, CXCL10, IFNB1, IL8, PIK3CD
*probability that a biological function is significantly involved in the analysis.
£activation state of the biological function; three cases are possible: activation, inhibition or ‘‘none’’, if the statistical significance is not sufficient for a clear conclusion
regarding the activation/inhibition.
&prediction of the activation state of the biological function; IPA uses z-scores to evaluate the activation/inhibition of the biological function. A negative score is
indicative of inhibition, while a positive score is indicative of activation. If the statistical significance is not sufficient for a clear conclusion regarding activation/inhibition,
we discuss the tendency toward activation/inhibition on the basis of the positive/negative activation z-score.
1genes involved in the corresponding biological function.
doi:10.1371/journal.pone.0091918.t002
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cells compared to LV, leading to higher viral replication and
higher apoptosis rate in vivo.
iii. Individual genes
TLR7 and TLR3 were both activated upon LV infection, but
not upon Lena infection (Figure S6). The lack of induction of
TLR3 and/or TLR7 might be a strategy developed by Lena to
escape the host immune response. Su et al. [65] showed that
inhibiting the TLR3/TLR7signaling pathway hinders an adequate
host response to PRRSV infection. However, Zhang et al. [66]
found that TLR3 and TLR7 were more highly expressed in cells
infected with a highly pathogenic PRRSV isolate compared to a
weakly pathogenic isolate. This discrepancy from our results might
be due to the differences in the immune responses triggered by
European PRRSV genotypes 1 and 3, which were used in this
study, compared to PRRSV genotype 2, which was employed in
[66]. Furthermore, although TLR4 was expressed in small
quantities (average FPKM = 0.4 in Lena), it was shown to be
more highly expressed in the Lena group than in the LV group
(FC = 5.98) and was expressed at an even lower level in the LV-
infected cells compared to mock-infected cells (Figure S6). TLR4
has been shown to intervene in viral infection with respiratory
syncytial virus (RSV) and mouse mammary tumor virus [67].
IFN-b and IFN-av were up-regulated following infection with
either LV or Lena, but IFN-b was more highly expressed in the
PAMs infected with LV (Figure 3). The difference in IFN-b
expression levels between LV and Lena had thus no apparent
impact on their replication rate in vitro, which was even slightly
lower for Lena. This would point to the previously proposed
mechanisms of impairment of the signaling pathway of IFN- b as a
main strategy used by PRRSV to block or delay apoptosis until
sufficient progeny have been produced [44,68]. Such impairment
could act via individual signaling pathways like RIG-I and Toll
like receptor or via a cross talk among several signaling pathways.
In addition, some structural proteins of the virus could explain the
delayed expression of INF- b [68].
It is worth mentioning that the involvement of IFN-av in
macrophage infection by PRRSV is reported here for the first
time, likely because this gene was only recently annotated in the
context of the structural and functional annotation of the porcine
immunome [69].
IL-10 was observed in the LV group, but not in the Lena group
(Table S2). Furthermore, while TNF-a was up-regulated in both
the LV and Lena groups, it was significantly up-regulated in the
LV group compared to the Lena group (Table S2). The induction
of TNF-a and IL-10 is used as a criterion for the classification of
PRRSV isolates [70]. The relative inhibition of TNF-a and IL-10
might be another mechanism employed by the Lena strain to
increase its virulence, as suggested for other PRRSV strains
[71,72].
In an in vivo transcriptomic analysis of PAMs [73], of the
potential antiviral functions reported to be significant, at least two
of the biological functions were also identified in this study: the
‘‘up-regulating IFN-induced genes’’ and ‘‘increasing intracellular
zinc ion concentration’’ categories. The intersection between the
genes found to be differentially expressed in vivo [73] and those that
were differentially expressed in this study between the mock and
the LV/Lena groups highlighted 22 genes (BRCA1, CCL2, CCR5,
DTX3L, GBP1, GBP2, HERC6, IFIH1, IFIT1, IFIT2, IFIT3, IRF7,
ISG15, MX1, PAPD5, PARP9, PLAC8, PPBP, RSAD2, SOCS1,
USP18 andXAF1). These genes form a highly significant network
centered on IFN signaling (Figure S7). This group of genes could
therefore be considered a hallmark of infection by type 1 and type
3 European strains, independent of the infection type (in vivo/in
vitro) and strain virulence (LV/Lena).
Transcriptional and post-transcriptional regulation and
differential promoter use upon infection of the PAMs
with the LV and Lena PRRSV strains
Most of the genes that were differentially expressed in the PAMs
following PRRSV infection were expressed as several isoforms that
were subjected to transcriptional/post-transcriptional regulation
and/or differential promoter usage. In the results section, we
classified these genes into three main groups (genes with one
isoform and one TSS, Figure S5-Group 1; genes with more than
one isoform and one TSS, Figure S5-Group 2; and genes with
more than one isoform and more than one TSS, Figure S5-Group
3).
The first two groups included genes crucial for the innate
immune response, which may be under stronger selection to
prevent the emergence of new isoforms and/or post-transcrip-
tional regulation. However, most genes (19) belonged to the third
group, suggesting that they could be subjected to positive selection
at the transcriptional and post-transcriptional regulation levels.
The analysis of alternative promoter usage highlighted the
complexity of transcriptional regulation during the infection of
PAMs with PRRSV. SLC22A15, a regulator of transmembrane
transport, was the only differentially expressed gene that appeared
to be significantly regulated at the promoter level, and this gene
was identified only in the LV vs. mock analysis. However, seven
other genes (MPDZ, ANAPC13, GPAT, ENSSSCG00000029349,
LIN54, ENSSSCG00000025855 and UBXN11) were differentially
regulated at the promoter level in the LV vs. Lena comparison.
MPDZ is directly involved in host-pathogen interactions [74],
whereas ANAPC13 and LIN54 are involved in cell cycle
progression [75,76].UBXN1 is involved in cytoskeleton remodeling
[77], and GPAT plays a role in lipid synthesis [78].
Conclusion
In this study, we used RNA-Seq to profile PAMs following
infection with two different strains of PRRSV to obtain a broad
overview of the response of PAMs to PRRSV infection. We
characterized and compared the cell responses to the two strains in
terms of canonical pathways and biological functions, as well as in
terms of individual genes. Therefore, our results increase our
knowledge of PRRSV infection by consolidating and enriching the
previous information generated using microarray technologies.
To the best of our knowledge, this is the first study in which
genes, isoforms, TSSs and differential promoter usage were
estimated based on RNA-Seq data obtained from PAMs infected
with PRRSV. However, further targeted experiments are needed
to validate and clarify these types of regulation and to determine
their potential effects during macrophage infection.
Supporting Information
Figure S1 Top network formed by genes that were differentially
expressed in (A) LV vs. mock and (B) Lena vs. mock comparisons
that are directly involved in cell death/survival. These two
biological functions are highly interconnected and are highlighted
in the networks as ‘‘cell death’’ and ‘‘cell survival’’. In the LV vs.
mock set, most genes were up-regulated, except forCD5, PYCARD
and ARG1, which were down-regulated. In the Lena vs. mock set,
except for HSPB1, all of the genes were up-regulated. The
networks were constructed by using focus molecules as ‘‘seeds’’
that were connected together to form a network including the
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genes in the list. If needed, other non-focus molecules from the
dataset were then added to complete the network. The resulting
networks were scored and then sorted based on the score. The
network scores represent the negative log of the p-value of the
likelihood that the network molecules were found together by
chance. Therefore, a high score represents a san index indicating
that the interconnection of the molecules within the network is
more likely to be true.
(PDF)
Figure S2 Example of top genes that were differentially
expressed between the LV and Lena groups (among the largest
fold changes). (I) Expressed only in the Lena and not in the LV
group: (A) RPL31 and (B) IL8. (II) Expressed in high quantities in
both the LV and Lena groups: (C) CCL2. (III) Expressed in the LV
group, but in a very low quantity in the Lena group: (D)ACADVL.
(TIFF)
Figure S3 Example of the top (among the largest fold changes)
differentially expressed genes (CXCL10) that were regulated
transcriptionally and post-transcriptionally. CXCL10was presentin
three isoforms, among which ‘‘TCONS_00046382’’ was differen-
tially expressed between the LV and Lena groups. CXCL10 was
also regulated at the TSS level, as it displayed three TSSs, among
which ‘‘TSS31082’’ was differentially regulated between the LV
and Lena groups.
(TIFF)
Figure S4 Cufflinks approaches for estimating (A) transcripts
and their abundances and (B) transcriptional and post-transcrip-
tional regulatory effects on overall transcript output. In Figure S4-
A: For the whole analysis, Cufflinks used the paired-end reads that
were aligned to the reference genome (Build Sus_scrofa.Sscro-
fa10.2.71.),using the TopHat software, to perform the spliced
alignments (a). Cufflinks starts by connecting the compatible
fragments in an overlap graph. Thus, Cufflinks applies Dilworth’s
Theorem, which yields a minimal set of paths that cover all of the
fragments in the overlap graph, by finding the largest set of reads
meeting the criterion that no two reads could have originated from
the same isoform (b,c). Subsequently, Cufflinks estimates transcript
abundance using a statistical model in which the probability of
observing each fragment is a linear function of the abundances of
the transcripts from which it could have originated (d). The last
step consists of maximizing the likelihood function for all possible
sets of relative transcript abundance to determine the set that best
explains the observed fragments (e). In Figure S4-B: (a) When the
abundance of isoforms A, B and C are grouped by TSS, the
changes in the relative abundance of the TSS groups indicate
transcriptional regulation (A+B vs. C). Post-transcriptional effects
are observed as changes in the levels of the isoforms ina single TSS
group (A vs. B) (Adapted from Trapnell et al. 2012).
(PDF)
Figure S5 Transcriptional/post-transcriptional regulation of the
genes involved in the top canonical pathways in the LV vs. mock,
Lena vs. mock and LV vs. Lena comparisons. (A) Un-spliced and
transcriptionally regulated genes,(B) spliced and post-transcrip-
tionally regulated genes and(C) spliced and both transcriptionally
and post-transcriptionally regulated genes. For each transcript,the
‘‘XLOC’’, ‘‘TSS’’ and ‘‘TCONS’’ suffixes correspond to the
genes, TSSs and isoforms, respectively. Differentially expressed
isoforms with different TSSs are transcriptionally regulated, while
isoforms with the same TSS are regulated at the post-
transcriptional level (Figure S4).
(PDF)
Figure S6 Differential expression ofTLR3, TLR4 and TLR7
between the LV and Lena groups. TLR7 and TLR3 were
significantly up-regulated in the LV group, while neither TLR7
nor TLR3wasmodulated in the Lena group. Although TLR4 was
expressed in small quantities (medium FPKM = 0.4 in Lena), it
was more highly expressed in the Lena group than in the LV
group (FC = 5.98) and was expressed at an even lower level during
LV infection than during mock infection.
(PDF)
Figure S7 Network formed by common genes that were
differentially expressed in the LV vs. mock and Lena vs. mock
comparisons from one side and in an in vivo study performed by
Zhou et al. (2001) from the other side. The canonical pathways
that were significantly affected by this group of genes are
highlighted with blue squares and include interferon signaling,
the activation of IRF by cytosolic pattern recognition receptors,
the role of hypercytokinemia/hyperchemokinemia in the patho-
genesis of influenza, the role of RIG1-like receptors in antiviral
innate immunity and the role of PI3K/AKT signaling in the
pathogenesis of influenza. The networks were constructed using
focus molecules as ‘‘seeds’’ that were connected together to form a
network using the genes in the list. If needed, other non-focus
molecules from the dataset were then added to complete the
network. The resulting networks were scored and then sorted
based on the score. The network scores represent the negative log
of the p-value of the likelihood that the network molecules were
found together by chance. Therefore, a high score represents an
index indicating that the interconnection of the molecules within
the network is more likely to be true.
(PDF)
Table S1 Summary of the reads generated per sample (mock,
LV and Lena). A. Numbers of RNA-Seq reads generated per
sample (mock, LV and Lena). B. RNA-Seq reads eliminated
following quality evaluation via FASTQC and Sickle. C. RNA-
Seq reads mapped to the pig genome (Build Sus_scrofa.S-
scrofa10.2.71.) using the TopHat v2.0.8 algorithm.
(DOC)
Table S2 Genes, isoforms, TSSs and promoter usage showing
differential expression in the LV vs. mock, Lena vs. mock and LV
vs. Lena comparisons. Genes_Mock_vs_LV: differentially ex-
pressed genes between the LV and mock infections; Genes_-
Mock_vs_Lena: differentially expressed genes between the Lena
and mock infections; Genes_LV_vs_Lena: differentially expressed
genes between the LV and Lena infections. Isoforms_-
Mock_vs_LV: differentially expressed isoforms between the LV
and mock infections; Isoforms_Mock_vs_Lena: differentially
expressed isoforms between the Lena and mock infections;
Isoforms_LV_vs_Lena: differentially expressed isoforms between
the LV and Lena infections. TSS_Mock_vs_LV: differentially
expressed TSSs between the LV and mock infections;
TSS_Mock_vs_Lena: differentially expressed TSSs between the
Lena and mock infections; TSS_LV_vs_Lena: differentially
expressed TSSs between the LV and Lena infections. Promo-
ters_Mock_vs_LV: differentially used promoters between the LV
and mock infections; Promoter_Mock_vs_Lena: differentially used
promoters between the Lena and mock infections; Promo-
ter_LV_vs_Lena: differentially used promoters between the LV
and Lena infections. Each page is composed of 7 columns: test_id,
gene_id, gene, gene-map, locus, sample_1, sample_2, status,
value_1, value_2, log2.fold_change, test_stat, p_value, q_value
and significant.
(XLS)
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